Tower Research Capital (TRC)’s Actinium Pharmaceuticals ATNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.47K Sell
2,478
-5,871
-70% -$8.22K ﹤0.01% 4491
2025
Q1
$13.4K Sell
8,349
-1,198
-13% -$1.93K ﹤0.01% 3365
2024
Q4
$12K Buy
9,547
+5,569
+140% +$7.02K ﹤0.01% 3661
2024
Q3
$7.48K Sell
3,978
-1,285
-24% -$2.42K ﹤0.01% 4047
2024
Q2
$38.9K Buy
5,263
+2,915
+124% +$21.6K ﹤0.01% 3288
2024
Q1
$18.4K Buy
2,348
+250
+12% +$1.96K ﹤0.01% 3074
2023
Q4
$10.7K Sell
2,098
-284
-12% -$1.44K ﹤0.01% 4218
2023
Q3
$14.1K Buy
2,382
+1,403
+143% +$8.31K ﹤0.01% 3711
2023
Q2
$7.26K Buy
979
+643
+191% +$4.77K ﹤0.01% 4571
2023
Q1
$3K Sell
336
-100
-23% -$893 ﹤0.01% 5169
2022
Q4
$5K Sell
436
-4,129
-90% -$47.4K ﹤0.01% 4834
2022
Q3
$33K Sell
4,565
-1,241
-21% -$8.97K ﹤0.01% 3514
2022
Q2
$28K Buy
5,806
+4,771
+461% +$23K ﹤0.01% 3431
2022
Q1
$6K Buy
1,035
+133
+15% +$771 ﹤0.01% 4848
2021
Q4
$5K Buy
902
+702
+351% +$3.89K ﹤0.01% 5128
2021
Q3
$2K Sell
200
-3,608
-95% -$36.1K ﹤0.01% 5231
2021
Q2
$30K Buy
3,808
+1,897
+99% +$14.9K ﹤0.01% 3476
2021
Q1
$15K Buy
+1,911
New +$15K ﹤0.01% 4091
2020
Q4
Sell
-1,481
Closed -$14K 5116
2020
Q3
$14K Buy
1,481
+321
+28% +$3.03K ﹤0.01% 3955
2020
Q2
$12K Buy
+1,160
New +$12K ﹤0.01% 3919
2015
Q4
Sell
-247
Closed -$13K 4454
2015
Q3
$13K Sell
247
-327
-57% -$17.2K ﹤0.01% 2081
2015
Q2
$45K Buy
574
+551
+2,396% +$43.2K ﹤0.01% 1447
2015
Q1
$2K Sell
23
-298
-93% -$25.9K ﹤0.01% 3722
2014
Q4
$57K Buy
321
+65
+25% +$11.5K 0.01% 954
2014
Q3
$51K Buy
256
+218
+574% +$43.4K 0.01% 1512
2014
Q2
$8K Buy
+38
New +$8K ﹤0.01% 2501